Extracellular vesicles (EVs) are released by most cell types but providing evidence for their physiological relevance remains challenging due to a lack of appropriate model organisms.
MAIN TEXT
Extracellular vesicles (EVs) collectively include exosomes, 50-200nm diameter membranous vesicles secreted from multivesicular endosomes (MVEs) fusing with the plasma membrane (PM), and microvesicles (MVs), 50nm-1µm diameter membranous vesicles that bud from the PM. Exosomes and MVs are released by a wide variety of cell types and are found in all organism investigated so far (van Niel et al., 2018) . Their implication in an increasing number of major physiological and pathological processes supports their putative role as essential intercellular messengers (Lo Cicero et al., 2015; Tkach and Théry, 2016) . Most of the data on the function of EVs such as exosomes, however, is gathered from transformed cancer cells and relies on the use of a heterogeneous population of EVs purified from cell culture supernatant or liquid biopsies. Consequently, the propagation of endogenous exosomes in vivo is largely unknown and data on their biogenesis and role in normal developing tissue and adult tissue homeostasis distinctly lags behind. Understanding EV biogenesis, transfer and fate in recipient cells, however, is of prime importance not only from a fundamental point of view, but also to assess their relevance in pathological conditions as well as their use as therapeutic delivery systems (Fais et al., 2016) . This apparent hiatus is largely due to the shortage of suitable models to visualize and track single endogenous EVs, and in particular exosomes in vivo from their site of production to their final destination in target cells (Hyenne and Goetz, 2017) . Previous studies visualizing EV release and transfer have been limited to the detection of larger extracellular structures or their transfer from transplanted transformed cells (Lai et al., 2015; Zomer et al., 2015) .
Our main aim was to develop an integrated model to study EV release, transfer and function, which combines in vivo imaging with sub-cellular resolution while retaining the in toto imaging scale. Due to their small size and transparency, zebrafish embryos elegantly match the single-cell precision of C. elegans research in a vertebrate system with relevant architectural homology with mice and human. We show here that zebrafish embryos can be used to track exosomes in vivo by expression of the CD63-pHluorin reporter. This fluorescent reporter is specifically targeted to (late-) endosomes and secreted on exosomes, allowing live visualisation of exosome release in single cells in vitro (Verweij et al., 2018) . Expression of CD63-pHluorin in zebrafish embryos revealed massive release of exosomes from the Yolk Syncytial Layer (YSL) into the blood flow that could be tracked in vivo throughout the animal up to their final destination. These exosomes are arrested and taken up by macrophages and endothelial cells of the caudal vein plexus (CVP) in a dynamin-dependent manner for degradation in lysosomes. Interference with syntenin-dependent exosome biogenesis in the YSL affected CVP growth, supporting a trophic role of these exosomes. Altogether, these data reveal for the first time the secretion, journey and the uptake in target cells of individual endogenous exosomes secreted in vivo, and key molecular mediators of these processes.
RESULTS

Zebrafish cells secrete EVs containing exosomal proteins
To investigate whether zebrafish could serve as a relevant model to study exosomes, we first assessed the presence of EVs in zebrafish embryos 3 days post fertilization (3dpf) by electron microscopy (EM). EM analysis revealed the presence of 100-200nm diameter vesicles clustered and enwrapped or free in the extracellular space (Fig 1A) . We also processed the cell-culture supernatant of the zebrafish fibroblast AB.9 cell line with a differential ultra-centrifugation protocol (Théry et al., 2006) . By electron microscopy we detected various vesicles in the size range of exosomes (~100nm) (Fig 1B) . Proteomic analysis on the same preparations identified a variety of zebrafish homologues proteins traditionally found in mammalian exosomes, including tetraspanins CD63, CD9, CD82, and several heat-shock proteins (HSPs), including HSP70 and HSP90 (Fig 1C, Suppl. table I) and similar to the markers identified in exosomes derived from Zmel cells, a zebrafish melanoma cell line (Hyenne et al., co-submitted) . This demonstrates that zebrafish cells release EVs that are enriched in the CD63 zebrafish ortholog, and supports the application in zebrafish of a fluorescent reporter that we recently used to visualize the fusion of multivesicular endosomes (MVE) with the plasma membrane (PM) in vitro, hCD63-pHluorin (Verweij et al., 2018) . Due to its pH-sensitivity, CD63-pHluorin primarily reports its 'extracellular pool' (i.e. PM and EVs) but obscures CD63 large intracellular pool present in acidic endosomal compartments (Sung et al., 2015) . Injection of ubi:hCD63-pHluorin plasmid-DNA (pDNA) at the single-cell stage of Casper zebrafish embryos resulted in mosaic, transient expression of CD63-pHluorin in multiple cell types, including epithelial, endothelial, neuronal, red-blood-and muscle cells without obvious developmental defect of the embryo (Fig 1D-E) . CD63-pHluorin associated fluorescence was localized at the PM of these cell types and to small, dotty structures potentially corresponding to CD63-pHluorin positive released EVs (Fig 1E, arrows) . As previously shown in cell lines (Verweij et al., 2018) , we could detect MVE-PM fusion events (Fig 1F, box 2-3) in vivo, which were pretty rare (~1 every 10 minutes) but with similar duration when compared to our observation in various cell lines in vitro (i.e. 20-30 sec) (Verweij et al., 2018) . Current technical limitation of imaging restricted the detection of MVE-PM fusion events in vivo to flat, stretched cells close to the dermis such as long-stretched fibroblast-like cell types (Fig 1F) .
A major pool of CD63 positive EVs is present in the bloodstream of zebrafish embryos
One of the postulated assets of EVs is their potential as extracellular carrier in longrange communication in vivo by entering the circulation (Thomou et al., 2017; Tkach and Théry, 2016) . Despite circumstantial evidence, this has never been studied directly in a relevant physiological in vivo model. In zebrafish embryos, the cardio-vascular system develops with a heart-beat and a first transient wave of erythrocytes as early as at 24 hours post fertilization (Hermkens et al., 2015) . Strikingly, in 3dpf zebrafish larvae expressing CD63-pHluorin, we could detect a large pool of CD63-pHluorin positive membranous structures carried by the blood flow in different parts of the vasculature throughout the body, including the brain and the gills (Fig 2A-B ; Suppl. Movie 1). EM analysis on blood vessels of ubi:CD63-pHluorin plasmid (p)DNA expressing embryos confirmed the presence of numerous single EVs in the size range of exosomes (~100nm), but also a minor fraction of trapped vesicles and multivesicular structures that labelled positive for immunogold associated to anti-GFP antibody (Fig 2C-E) . While the initial observations were done on 3dpf embryos, we could detect CD63 positive EVs as early as 24h (1dpf), at the onset of the blood flow (data not shown). This observation opened the opportunity to track individual endogenous EVs in vivo.
The yolk syncytial layer (YSL) releases CD63-pHluorin positive exosomes in the bloodstream
Next, we aimed to identify the cellular origin of the CD63 positive EVs detected in the bloodstream. The large surface area of the yolk syncytial layer (YSL), its highly differentiated secretory apparatus, high lysosomal activity, and cytoplasmic multivesicular structures by electron microscopy (Walzer and Schönenberger, 1979 ) made a plausible candidate for the vast number of EVs detected in the blood flow. Moreover, until the Duct of Cuvier closes at day 2.5, then forming the common cardinal vein, the YSL is in direct contact with the blood flow (Helker et al., 2013) . Video-enhanced Nomarski microscopy revealed numerous EVs in the large interstitial space between the YSL and the overlying epidermis, at and even before the onset of blood circulation (Supp Fig 1A) . Injection of ubi:CD63-pHluorin pDNA directly in the YSL at the 1000-cell stage (4hpf) (Supp Fig 1B) allowed for tissue-specific expression of CD63-pHluorin and circumvents the need for tissue specific promoters (Fig 3A) . Immuno-gold labelling for GFP on thin cryo-sections of YSL CD63-pHluorin expressing 3dpf zebrafish embryos showed a massive number of vesicles ranging from 80-200nm in size immediately above the YSL and in direct contact with the blood (Fig 3B-C Fig   1C) . Consistently, CD63-pHluorin positive EVs were detected in the blood flow after tissue specific expression of CD63-pHluorin in the YSL (Suppl. Movie 2), and EM analysis of the blood vessels confirmed the nature of the fluorescent structures as single vesicles enriched in CD63-pHluorin in the size range of exosomes (~100-150nm) (Fig 3D) . Moreover, YSL derived EVs that were observed in the blood flow accumulated in the caudal vein plexus (CVP) only in embryos with a detectable bloodstream (Fig 3E) . This indicates that YSLderived EVs enriched in CD63-pHluorin are continuously released in the blood flow and can circulate through the entire embryo to reach their remote destination.
and Supp
Next, we characterized the nature of these fluorescent EVs by dissociating 3dpf CD63-pHluorin YSL expressing and non-expressing control embryos using Collagenase I treatment, and isolating EVs from the supernatant with a differential ultra-centrifugation protocol (Théry et al., 2006) . Immunogold labelling followed by electron microscopy observation of the CD63-pHluorin YSL expressing embryos derived pellet (Supp Fig 1C) confirmed the presence of vesicles heavily labelled for CD63-pHluorin with a morphology and a size (80-120nm) comparable to those observed by EM in situ (Fig 3D) . Whereas larger EVs were visible in the pellets, less than 5% of the labelled vesicles was larger than 150nm in size (Supp Fig 1C,D) . Nanoparticle tracking analysis (Supp Fig 1E) of the 100 000g pellet of both conditions did not show significant differences in terms of size and number, suggesting that the expression of CD63-pHluorin in the YSL did not profoundly affect the release of EVs compared to basal condition. Pellets from both conditions were then further processed by immunoprecipitation against GFP using GFP-Trap agarose beads, followed by quantitative label-free proteomics analysis of the pull-down fraction. We quantified enrichment of specific proteins using non-injected zebrafish derived EV pellet as background. The most enriched proteins were Syntenin-a, TSG101, Rab7, ADAM10 and V1 ATPase subunit B2 that were only detected in the injected YSL EV-fraction and Alix (34x). Other YSL EV-enriched proteins included CMHP4c, EHD1, Cation-Independent Mannose 6-phosphate Receptor, Flotillin 1, CD63, CD82, the lysosomal acetyltransferase HGSNAT and the lysosomal amino acid transporter PQLC2. (Fig 3F, Supp Table II ). Of note, several of the enriched proteins are implicated in one of the machineries involved in exosome biogenesis in endosomes in vitro (Baietti et al., 2012) . These data strongly support an endosomal origin of YSL-derived EVs. This conclusion was reinforced by the presence of large MVEs that contain CD63-pHluorin positive ILVs (Fig 3G) in the YSL. Thus, CD63-pHluorin positive YSL-EVs present all the characteristics of endosome-derived exosomes as previously defined (Gould and Raposo, 2013) . Finally, these YSL-exosomes were enriched for Molecular function GO terms "Anion binding", "Small molecule binding" and 'Transporter activity', the latter being characterized by the presence of several Solute Carrier Family proteins, including zinc and amino acid transporters slc30a1a and slc3a2b. YSL derived exosomes displayed similarities with the composition of the AB.9 caudal fibroblast derived exosomes and to a certain extent with Zmel zebrafish cell line derived EVs ( Supp Table I ; (Hyenne et al., co-submitted) ), as they both contain major actors of exosome biogenesis (Alix, TSG101, Chmp4C, tetraspanins).
Nevertheless, physiological (this study) and pathological (Hyenne et al., co-submitted) exosomes differed by their composition that could be linked to their respective (patho)physiology ( Supp Table II ). Altogether, these data strongly suggest that expression of CD63-pHluorin in the YSL reveals the release of exosomes in the bloodstream of developing embryos.
YSL-derived CD63 positive exosomes adhere to endothelial cells of the caudal plexus and are actively endocytosed by patrolling macrophages
Having determined a cell layer of origin and transportation route of CD63 positive exosomes, we live-tracked them in the blood vasculature to identify potential target cells. Our data revealed an accumulation of dotty signals (Fig 3A) likely corresponding to immobilized exosomes in the blood, in particular in the caudal part of the vasculature. This area comprises the caudal artery (CA), and a complex, venous vascular network in between and originating from the cardinal vein (CV), called the caudal vein plexus (CVP) (Fig 4A) .
A maximum projection time-lapse movie of this region at higher magnification suggested an interaction between the labelled exosomes and the vessel wall (Fig 4A, Supp Movie 3A). Indeed, high-speed imaging of the cardinal vein confirmed the transient interaction of exosomes passing through the blood vessels with the plasma membrane of endothelial cells (Fig 4B, Supp Movie 3B) . To visualize the extent and the exact localization of exosomes that adhere in the caudal part of the vasculature, we created a heat-map overlay of 6 individual YSL CD63-pHluorin pDNA injected embryos 3dpf (Fig 4C) . Strikingly, the vast majority of exosomes was selectively arrested in the venous plexus and the caudal vein, but not in the caudal artery. This behaviour is remarkably similar to what was observed for intravenously injected Zmel1 EVs (Hyenne et al., co-submitted) , suggesting a common behaviour for EVs of distinct origin and labelled with different tags in the blood flow of zebrafish embryos. In high-magnification images we identified motile cells that crawled on the surface of the endothelial vessels and that contained labelled exosomes in intracellular compartments, likely resulting from their endocytosis (Fig 4D) . Apart from endothelial cells, the lumen of the caudal vein plexus hosts a number of embryonic macrophages that continuously scavenge their environment and stand out by their relative high motility (Murayama et al., 2006) . In Tg(kdrl:HRAS-mCherry) zebrafish embryos, these macrophages can be distinguished by their mCherry-positive compartments, probably as a result of endocytosis of (apoptotic) fragments of mCherry-expressing endothelial cells. By exploiting a Tg(mpeg1:mCherryF) fish line that specifically labels macrophages in red, we could identify these exosome internalizing cells as patrolling macrophages (Fig4E, Supp Movie 4A).
Subsequent time-lapse imaging of macrophages in the caudal plexus of Tg(kdrl:HRAS-mCherry) fish expressing CD63-pHluorin in the YSL revealed an active form of uptake of exosomes by macrophages that projected dendrites or pseudopodia, able to interact and 'harvest' exosomes from the surface of endothelial cells (Fig 4F; Supp Movie 4B). Similar 'harvesting' by patrolling macrophages was also observed for melanoma-derived exogenous EVs (Hyenne et al., co-submitted) , suggesting common mechanisms for uptake of EVs of distinct origin.
To further investigate the specificity of the uptake of labelled exosomes by macrophages of the CVP, we injected the yolk of CD63-pHluorin YSL expressing Casper embryos at 1dpf with 1.5 ng/nl BODIPY-C12 to specifically label the high amount of VLDL particles produced by the YSL and released in the blood flow, and to visualize the lumen of the blood vessels (Miyares et al., 2014) . The BODIPY fluorescence was readily visible in the vasculature but was not overlapping with CD63-pHluorin labelling in the blood flow, confirming the nature of CD63-pHluorin positive EV as exosomes and not as derivatives of VLDL. Moreover, we did not observe any BODIPY signal in macrophages, while exosomes were again actively endocytosed (Fig 4G; supp Movie 4C). We did not observe an early decrease in fluorescence signal of CD63-pHluorin early (~3 minutes) after uptake (Fig 4G) , in line with the observation of a large number of exosomes in the lumen of macrophages ( Fig   4E-F ), suggesting temporal "storage" and/or a delayed targeting to acidic endosomal compartments. Altogether, these data revealed a specific uptake of exosomes by macrophages in intracellular compartments that become acidic at later time point and/or that initially maintain connection with the cellular exterior.
YSL-exosomes are taken up and degraded by endothelial cells
The specific interaction of labelled exosomes with the venous -(Supp Movie 3) but not the arterial vasculature (Fig 4C) , suggested potential implication of different shear forces exerted on EVs (Hyenne et al., co-submitted) between the venous and arterial blood flows. Drug treatment decreasing pacemaker activity (Vermot et al., 2009) , and consequently the shearforce of the blood flow, did not lead to a visible increase of the association of exosomes with the caudal artery (Supp Fig 1F) . This indicates the implication of additional factors, such as expression of adhesion molecules, in this interaction.
We further analysed the dynamic of interaction between exosomes and the endothelium by using high-speed imaging of the caudal vein of YSL CD63-pHluorin pDNA injected embryos 3dpf. We observed rolling, arrest and accumulation of exosomes on the endothelial wall of the vein (Fig 5A, Sup Movie 5A) . Quantification of the duration of the interaction between exosomes and the venous vessel wall indicated that exosomes stay attached for an average duration of 3 min (Fig 5B) . This behaviour is similar to that of exogenous melanoma-derived EVs (Hyenne et al., co-submitted) and reinforced potential molecular interactions between exosomes and specific receptors at the surface of venous endothelial cells.
We observed that exosomes interacted transiently with endothelial cells and then disappeared (Fig 5B, Supp Movie 3, 5A ), suggesting either their uptake by endothelial cells and targeting to acidic endosomal compartments, their re-entry into the blood flow or their dispersion outside of the vasculature. EM analysis of YSL CD63-pHluorin pDNA injected zebrafish revealed, qualitatively, that the former occurs, as we observed clusters of YSL derived exosomes immunogold labelled for GFP, and mixed with dense aggregates in endolysosomal structures in endothelial cells of the caudal plexus (Fig 5C) . This suggested a degradative fate of exosomes that we further investigated by treating zebrafish embryos with a specific inhibitor of the vacuolar H(+)-ATPase, Bafilomycin A1 (BafA), that elevates endosomal pH and decreases lysosomal degradation (Christensen et al., 2002) . Strikingly, incubation for 2h with 100nm BafA showed that, consistent with sites of exosomesendothelium interaction (Fig 4C) , endothelial cells of the vein plexus and cardinal vein but not the caudal artery endocytosed considerable amounts of CD63-pHluorin exosomes over time, mostly concentrating at peri-nuclear areas (Fig 5D, nuclei indicated with (N) ). This accumulation, after only two hours of treatment, suggests that exosomes are mainly and continuously taken up by endothelial cells to be degraded in acidic endo-lysosomes.
We then tested whether exosomes could propagate beyond vascular endothelial walls.
For this, we imaged the area of the caudal vein plexus and clearly observed labelled exosomes outside of the posterior cardinal vein (PCV) (Fig 5E, F ; Suppl Movie 5B). Even though we observed some of the larger fluorescent exosome clusters concentrated adjacent to the CVP, we detected high levels of fluorescent exosomes outside of the vasculature throughout the whole embryo, notably visible where covering the muscle segments and flowing in the neural tube (Suppl Movies 5B-C). The motility of the exosomes we observed outside the vasculature was irregular and resembled Brownian motion, clearly distinct from the dynamics of intracellular endosomal transport (Suppl Movie 5B). However, in muscle cells, Bafilomycin A treatment (Supp Movie 5D) did not show accumulation of YSL derived exosomes as observed for endothelial cells. The large majority of endocytosed exosomes was thus observed in endothelial cells and to a lesser extent in patrolling macrophages but not in other cell types, highlighting the specificity for targeted cells.
Uptake of YSL-derived exosomes by endothelial cells relies on scavenger receptors and dynamin-dependent endocytosis
This specific interaction of exosomes with target cell types likely relied on specific receptors (van Niel et al., 2018) . The visualization of internalized CD63-pHluorin exosomes with BafA treatment, allowed us to interfere with general uptake mechanisms by inhibiting dynamin, a key regulator of clathrin dependent and independent endocytosis (Ferguson and De Camilli, 2012) . We treated 2dpf YSL CD63-pHluorin expressing Tg(kdrl:HRAS-mCherry) embryos, expressing mCherry in the vasculature, with 3µM of dynamin inhibitor Pyrimidyn-7 prior to BafA treatment. Strikingly, we observed a near complete block of exosome uptake by endothelial cells (Fig 6A) , excluding the uptake mechanisms of exosomes via dynamin independent pathways and possibly macropinocytosis (Harper et al., 2013) . Mander's coefficient (M2) of the green signal (exosomes) overlapping with the red signal (endothelium) revealed an average decrease of more than 10-fold of the uptake (Fig 6B) . Comparison of Mander's coefficient after 180-degress rotation excluded potential interference of random overlap (Sup Fig 1G) . Similar quantification in ctrl or Pyrimidyn-7 condition showed a 5-fold reduction of uptake in macrophages (Fig 6C) .
To assess the efficiency of exosome uptake, we performed 4D imaging of the Cardinal Vein (CV) of 3dpf YSL CD63-pHluorin expressing Tg(kdrl:HRAS-mCherry) embryos treated with 100nM BafA. Time-lapse imaging indicated that exosomes accumulated over the ~1h timecoursed imaged (Supp Movie 6A), whereas a z-stack and a 3D rendering of the same z-stack showed a substantial presence of internalized exosomes per cell (Supp Movie 6B). Similar findings were obtained at 2dpf (data not shown). Together, this indicates that exosome uptake by the ECs of the CVP is not a sporadic event, but occurs in a continuous fashion. We next focused on potential receptors able to specify this endocytosis to endothelial cells.
Interestingly, the CVP area harbors scavenger endothelial cells (SECs) that interact in a scavenger-receptor mediated manner with liposomes of 100nm injected in the circulation (Campbell et al., 2018) . Scavenger receptors have been also reported in vitro to mediate exosome uptake (Plebanek et al., 2015) and are expressed on endothelial cells and macrophages and is conserved in teleost (Poynter et al., 2015) and mediate dynamindependent endocytocis (Jang et al., 2014) . To investigate whether scavenger receptors are implicated in exosome uptake in vivo, we injected dextran sulfate (DexSO 4 -500K), a known competitive ligand for scavenger receptors (Lysko et al., 1999) , intravenously in CD63-pHluorin YSL expressing Tg(kdrl:HRAS-mCherry) embryos prior to BafA treatment.
Strikingly, we observed a decrease of more than 4-fold of the green signal (EVs) overlapping with the red signal (endothelium) (Fig 6D-E) , indicating that endogenous exosomes competed with DexSO 4 -500K for their uptake by the same class of receptors. We did not observe a significant decrease in uptake in macrophages (Sup Fig 1H) .
This set of data revealed that in vivo, endogenous exosomes are specifically internalized by specialized veinous endothelial cells in a dynamin-and scavenger receptor dependent pathway to be targeted to lysosomes for degradation.
Production of YSL-derived exosomes relies on a syntenin-dependent biogenesis pathway and supports vasculogenesis of the caudal vein plexus
The enrichment for a Syntenin-Alix mediated machinery in YSL-exosomes ( Fig 3F) led us to interfere with their generation and further investigate their potential function in vivo.
A previous study in zebrafish reported the expression of syntenin-a, notably in YSL, at different stages of development (Lambaerts et al., 2012) . Depletion of syntenin-a in the whole embryo in the same study revealed defects in epiboly progression and body-axis formation during early zebrafish development whereas depleting syntenin-a solely in the YSL only affected epiboly in 30% of the embryos and resulted in a well-formed axis in all embryos. We co-injected one of these morpholino oligonucleotides, validated in conformity to recently published guidelines (Stainier et al., 2017) , targeting the translation start site in syntenin-a transcripts (SyntA MO), or control morpholino (Ctrl MO) together with CD63-pHluorin pDNA specifically in the YSL of Tg(kdrl:HRAS-mCherry) embryos 4hpf. Of note, in our experiments most embryos displayed normal development but showed a small delay in hatching and increase in mortality (Fig 7A-C) . When considering only embryos with normal development (>50% in both conditions), whole body analysis showed expression of CD63-pHluorin in the YSL (Fig 7A) but a profoundly diminished number of fluorescent exosomes in the blood flow for the SyntA MO compared to the Ctrl MO condition (Fig 7D,E) that could be rescued by co-injection of MO-insensitive wtSyntenin-A plasmid DNA ( Sup Fig 2A,B) .
This suggests that syntenin is implicated in CD63 positive exosome biogenesis in the YSL in vivo and that endogenous exosome biogenesis can be manipulated. Incubation of these embryos for 2h with 100nm BafA confirmed the near absence of exosomes in the CVP, corresponding with a 20-fold reduction of the uptake of exosomes by endothelial cells in this region (Fig 7F) . While we did not observe any major defect in angiogenesis or growth of SyntA MO embryos at 3dpf (Fig 7C) , we did observe a decrease of ~18% in the height of the CVP between SyntA MO and Ctrl MO treated embryos (Fig 7G-H) , suggesting a role of exosomes produced from the YSL in the development of the CVP by taking them up and targeting them to lysosomes. Finally, we aimed to further assess the effect of YSL-exosome depletion on CVP growth. For this, we performed imaging of YSL SyntA MO and Ctrl MO injected embryos over time between 35-40hpf and quantified the number of nuclei and the expansion of the vascular bed (Fig 7I-M) . While the nuclear density was comparable, the growth of the CVP as well as the cell proliferation was lower in SyntA MO YSL-injected compared to Ctrl MO YSL-injected embryos (Fig 7I-K) , whereas cellular motility seemed unaffected. Together, this indicates that YSL exosomes support CVP growth, mainly by affecting cell proliferation.
Collectively, these data demonstrate that endogenous biogenesis of exosomes can be modulated, revealing physiological effects in defined target cells.
DISCUSSION
Until now, the development of a model to explore the release, journey and targets of endogenous exosomes in vivo had been hampered by the small size of the exosomes and the lack of appropriate methods to label them. A recent study reported the use of CD63-GFP in transgenic rats (Yoshimura et al., 2016) that demonstrated its usefulness for the ex vivo analysis of EV transfer to organs and bodily fluids but that was limited in its suitability for in vivo imaging. Here, we sought to fill that void by exploring a vertebrate model suitable for in toto imaging while maintaining sub-cellular and even supra-optical resolution. The CD63-pHluorin strategy has been recently shown to be an accurate in vitro model to explore new facets of the molecular mechanisms that control the biogenesis and secretion of exosomes (Verweij et al., 2018) . Our study demonstrates that the CD63-pHluorin reporter can be used in vivo to investigate the molecular regulation of exosome secretion. This approach, however, is currently still limited by a technological latch that hinders quantitative observation of bursts of fluorescence in cells that are not flat. In our model, we observed a relatively limited number of fusion events compared to transformed cell lines in vitro, which is in line with in vitro experiments indicating lower fusion activity for non-transformed cells (Verweij et al., 2018) as well as increased presence of exosomes in bodily fluids of cancer patients (Galindo-Hernandez et al., 2013; Logozzi et al., 2009) . Interestingly, the transposition of this tool in vivo also provided a model allowing single vesicle tracking from their site of production to their final destination, and might be useful to investigate the dynamics of body fluid flows with high precision (Bachy et al., 2008) .
We observed a large number of fluorescent vesicles in the blood after ubiquituous expression of CD63-pHluorin. IEM labelling confirmed that CD63-pHluorin was associated to vesicular structures (Sup Fig 1C, 2D) . Using tissue-specific expression, we could trace the origin of these exosomes, and identified the Yolk Syncytial Layer (YSL), a secretory cell layer in direct contact with the blood, as one of the providers of endogenous exosomes that reach the rest of the organism. Mass spectrometry analysis of EVs derived from cell lines (AB.9, Zmel) and embryos in our study and in (Hyenne et al., co-submitted) showed a common composition and highlights a consistent presence of proteins involved in exosome biogenesis by the syntenin-Alix-ESCRT-III pathway, previously reported in vitro (Baietti et al., 2012) . Our data strongly suggest that the EVs followed in this study are likely of endosomal origin, although we cannot exclude the contribution of the plasma membrane of the YSL as source of EVs. Of note, treatment of embryos with GW4869 did not affect exosome release from the YSL (Supp Fig 2E) , suggesting that at least for this source of exosomes, ceramide is not a major regulator of their biogenesis (Trajkovic et al., 2008) . These data suggest that in vivo, the syntenin-Alix-ESCRT-III pathway is among one of the essential pathways for exosome biogenesis, opening avenues to interfere with EV generation and function in vivo.
Our initial explorations uncovered endothelial cells and patrolling macrophages as recipient cells, strengthening the notion of targeted communication by exosomes. Although we cannot exclude a specific role of YSL derived exosomes once taken up by macrophages, these scavenger cells may harvest exosomes dwelling at the surface of endothelial cells to regulate the steady state level of EVs in the circulation (Imai et al., 2015) . However, we also observed that the internalizing compartments containing EVs 1) do not immediately acidify (Fig 4G) , and 2) might be internalized slower, as we did not need to use Bafilomycin A treatment to visualize uptake in macrophages and still observed green EVs in macrophages after prolonged incubation with DS500K (Supp Fig 1H) . This would be compatible with a functional interaction between the EVs and the macrophage, recently demonstrated in a cancer setting (Gabrusiewicz et al., 2018) , and might be part of an immune surveillance function analogous to Kupffer cells (Jenne and Kubes, 2013) . In zebrafish, we show that endogenous exosomes are mainly targeted to the veinous endothelial cells of the CV(P).
These cells show functional homology with specialized Liver Sinusoidal Endothelial Cells (LSECs) in higher vertebrates (Campbell et al., 2018) , indicating inter-species correlation with the targeting of injected EVs to the liver in murine models (Charoenviriyakul et al., 2017; Wiklander et al., 2015) . LSECs clear soluble macromolecules and small particles from the circulation and in humans possess the highest endocytic capacity of all cells (Poisson et al., 2017) . In older vertebrates, jawless, cartilaginous and bony fish, cells resembling the LSEC are located at different locations outside the liver and are collectively called Scavenger Endothelial Cells (SECs) that are similarly central to the removal and catabolism of a variety of macromolecules from the circulation (Seternes et al., 2002) .
We show that the uptake mechanisms of EVs by endothelial cells in the CV(P) implicate Scavenger Receptors and dynamin-dependent endocytosis. Indeed, various scavenger receptors internalize their ligands in a dynamin-dependent manner and traffic to lysosomes (Fukuda et al., 2011) . Scavenger receptors, such as Stabilin-2, have been recently described as mediating the uptake of 100nm-sized anionic liposomes in zebrafish (Campbell et al., 2018) .
This suggests that exosomes, having a negative z-potential (due to the presence of anionic lipids), could bind in a similar fashion to these receptors, independently of a specific ligand present on the exosomal membrane.
The lysosomal fate of YSL-derived exosomes in endothelial cells echoes data showing that uptake and catabolism of exosomes in lysosomal compartments is likely a major fate as described in vitro (Tian et al., 2010) . This pathway would allow catabolism of EV content and provide a source of amino acids, nucleic acids, lipids and ions to recipient cells. Although we cannot rule out a structural function of YSL derived EVs during development, e.g. in patterning or differentiation (McGough and Vincent, 2016) , the effect we observed on CV and CVP development when interfering with EVs biogenesis also suggests that endothelial cells may uptake and process EVs in lysosomes to use them as a source of macromolecules for their own development (Yao et al., 2017) . It is also possible that these exosomes provide an extracellular source of membrane to allow for expansion of the vascular bed, analogues to the involvement of late-endo/lysosomes in protrusions and neurite outgrowth (Naegeli et al., 2017; Raiborg et al., 2015) . In accordance with this, we observed a lower proliferation rate of CVP endothelial cells with reduced levels of CD63 exosomes coming from the YSL (Fig 7J) .
These data raise the possibility that uptake of exosomes by LSEC, beyond a simple removal role of exosomes from the circulation, indeed may support a trophic link between the YSL and LSCEs.
The presence of numerous EVs in the bloodstream but also in the interstitial fluid (ISF) of developing zebrafish embryos strengthens ex-vivo observations of the presence of EVs in both fluids (Gromov et al., 2013; Johnstone et al., 1989) . Recent evidence indicates that exosomes or EVs containing miRNAs can also in-and extravasate biological barriers to access in ISF under physiological conditions (Thomou et al., 2017) but the YSL in zebrafish is directly connected with the ISF, providing a direct way for exosomes from YSL to access the ISF. The motility of the CD63-pHluorin positive exosomes we observed outside the vasculature was irregular and resembled Brownian motion (Suppl Movie 5B), clearly distinct from the dynamics of intracellular endosomal transport. Of note, Bafilomycin A treatment (as in Fig 5D) did not show accumulation of YSL derived exosomes in other cells such as the highly abundant muscle cells (Suppl Movie 5D). These observations would exclude uptake and lysosomal degradation as a major way to use EVs as a source of macromolecules by other cells than endothelial cells. Of note, our proteomic analysis revealed the presence and enrichment for various lipid-, amino acid and ion transporters that could support a role of YSL-derived exosomes as 'macromolecule dispenser' to surrounding cells, as these transporters could potentially mediate the bioavailability of exosomal contents (Allen and Cullis, 2013). All in all, the presence of these EVs in various bodily fluids supports a general role in metabolism, e.g. in nutrient delivery, and makes a specific role in other YSL functions, e.g. embryonic patterning, less likely. Nevertheless, we cannot exclude that these EVs are used to exchange genetic information between cells in vivo as shown recently (Ashley et al., 2018; Pastuzyn et al., 2018; Zomer et al., 2015) and future development of adapted tools as described in vitro (Yim et al., 2016) are required to explore these functions in detail.
Despite its several advantages, we cannot exclude that in this model, expression of this reporter might affect exosome secretion or composition. Nevertheless, nanoparticle tracking did not show a significant change of the number of particles between non-injected and CD63-pHluorin YSL expressing embryos, and proteomics indicated the presence of endogenous zCD63 in the YSL-CD63-pHluorin labelled exosomes. Another potential downside of our approach might be that expression of a TSPAN-reporter may only label a subpopulation of YSL-derived exosomes as CD63 may not be equally enriched in all exosome subpopulation (Kowal et al., 2016) . Larger (>150nm) vesicles, predominantly negative for CD63-pHluorin, suggest the presence of different sub-populations in our model. Isolating a subpopulation from the heterogenous family of EVs with this reporter present however the advantage to target specific fate or functions. Future studies using other TSPAN-pHluorin markers, including CD81, CD82, or CD9 (Verweij et al., 2018) , could aid to cover the whole spectrum of EVs. The present study was restricted to the YSL, excluding from our observation all EVs released by other cell types that might represent up to 90% of the pelleted vesicles from dissociated fishes (Supp Figures 1C, 2D) . Development of future strains with cell type specific expression will allow to investigate the various roles of exosomes secreted under physiological and pathological conditions by nearly all cell types investigated so far. In addition, combining cell-type specific expression of TSPAN-pHluorin markers with proteomic analysis of immuno-isolated exosomes could potentially be used to discover pathological bio-markers for each producing cell type targeted in vivo. What also might be considered as a drawback in some applications is that we use a pH-sensitive GFP, meaning that EVs that are taken up in recipient cells will in most cases likely end up in acidified compartments, resulting in quenching of their fluorescence. In this study, we do however show that bafilomycin treatment reverts this acidification and consequently quenching of fluorescent EVs and the addition of a pH-insensitive fluorescent label to CD63-pHluorin can also be considered.
In this study we opted for the morpholino (MO) strategy to achieve a tissue specific knock-down of Syntenin-a in the YSL. Although generally targeted mutagenesis using CRISPR/Cas9 would be the method of choice, the generation of a null allele would not affect maternal contribution of syntenin-a mRNA (Lambaerts et al., 2012) until reaching F3, and maternal-zygotic mutants will likely have too broad effects to address our specific point.
While we did initiate the generation of a null line (data not shown), we realized that since exosome secretion from the YSL could be observed as early as 1dpf, the use of MO injected in the YSL was preferred to 1) be able to affect maternal contribution of syntenin-a mRNA and 2) achieve tissue specific knock-down of Syntenin-a. We are well aware that the application of MO in zebrafish has to be approached with caution, and proper controls are needed to distinguish specific phenotypes from off-target effects, as outlined in recently published guidelines (Stainier et al., 2017) . The specific MO we applied has been used in a previous publication and complies with the additional guidelines as recently set out (Lambaerts et al., 2012; Stainier et al., 2017) . In addition, we titrated the MO for its ability to sufficiently block exosome secretion while minimizing mortality, and performed an additional rescue experiment ( Suppl Fig 2A) . Future studies with Syntenin-a KO lines will be indispensable to deepen our understanding of the contribution of this exosome biogenesis pathway to exosome physiology in vivo, but might require tissue-specific KO.
Importantly, the study of Hyenne et al (co-submitted) also used zebrafish embryos to investigate the behaviour and fate of systemically injected exogenous exosomes originating from zebrafish melanoma cells. Whereas previous studies have indicated how tumourexosome integrins determine their organotropism (Hoshino et al., 2015) , the combination of both models presented here reveals common uptake mechanisms between exogenous/pathological exosomes and endogenous/physiological exosomes, an interesting phenotype that has never been explored before at this scale. How circulating EVs target specific cell types at distance remains to be solved, mostly because this step could not be Baietti, M.F., Zhang, Z., Mortier, E., Melchior, A., Degeest, G., Geeraerts, A., Ivarsson, Y., Zomer, A., Maynard, C., Verweij, F.J., Kamermans, A., Schäfer, R., Beerling, E., Schiffelers, R.M., de Wit, E., Berenguer, J., Ellenbroek, S.I.J., et al. (2015) . In Vivo Imaging Reveals Extracellular Vesicle-Mediated Phenocopying of Metastatic Behavior. Cell 161, 1046-1057. 
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EXPERIMENTAL MODEL AND SUBJECT DETAILS
Zebrafish strains
Zebrafish were staged and cared for according to standard protocols (Westerfield) . All fish are housed in the fish facility of our laboratory, which was built according to the local animal welfare standards. All animal procedures were performed in accordance with French and European Union animal welfare guidelines. We performed our analyses at 3dpf. At this developmental stage, sex ratios cannot be determined (gonad differentiation begins around 25dpf). Adult density was maintained at ~7-8 fish/L, and fish were fed twice daily with artemia and dry food (SDS-400, DIETEX France). Water temperature was maintained at 28°C.
Cell lines
AB.9 (ATCC CRL-2298) cells are fibroblast obtained from the caudal fin of an adult AB strain zebrafish. AB.9 cultures were grown in Leibovitz-L15 CO 2 -independent medium supplemented with 15% heat-inactivated bovine serum at 28°C and passaged when reaching 90% confluency (1-2 times/week).
METHOD DETAILS
Construction of pUbi-CD63-pHluorin
pUbi-CD63-pHluorin was constructed by first cloning CD63-pHluorin (human CD63; sequence identical to Verweij et al., 2018) using primer pairs 5'-GGGGACAAGTTTGTACAAAAAAGCAGGCTGGatggcggtggaaggagga-3' (fwd) and 5'-GGGGACCACTTTGTACAAGAAAGCTGGGTCctacatcacctcgtagccacttct-3' (rev) into pDONR221 (Gateway, Invitrogen). pDONR221-CD63-pHluorin was subsequently recombined with p5E-ubi (Addgene plasmid # 27320), p3E-polyA 153, and pDEST R4-R3 (Gateway, Invitrogen) to create pUbi-CD63-pHluorin.
Morpholino injection
The MO against zSyntenin-A, and Standard Control oligo were purchased from GeneTools, used at 1:4 dilution from a 1 mM stock, and injected at 0.5-1.0 nL. The Synt-a MO has been previously validated for its effect on the YSL (Lambaerts et al., 2012) . To minimize potential off-targets effects in the current study, the optimal MO concentration for YSL-injection was titrated as the minimal concentration causing the studied phenotype while minimizing mortality or phenotypic abnormalities compared to control.
Plasmid DNA injections
To induce expression of CD63-pHluorin, embryos were injected at the one-cell stage (for ubiquitous expression) or at 4h in the YSL (for YSL-specific expression). On the next day, injected embryos were inspected under a stereomicroscope. Only embryos that developed normally were assayed.
VLDL labelling
BODIPY C12 was dissolved in canola oil as lipid (slow release) carrier at 1.5 μg/μl; approximately 5nl was injected in the yolk per embryo.
Decreasing pace-maker activity
Lidocaine was dissolved in ethanol and used at 640µM. After 2h incubation, zebrafish pacemaker activity was assessed by recording the heart-beat for 20 seconds at high speed (30Hz) using a video microscope with stage incubator maintained at 28°C.
Live fluorescent imaging
Embryos were anesthetized with tricaine and embedded in 1.5% low melting point agarose.
For most experiments, embryos were imaged at 3dpf. Recordings were performed at 28°C using a Nikon TSi spinning-wide (Yokagawa CSU-W1) microscope, equipped with a 60x CFI Plan Apo IR SR W NA 1.27, a sCMOS 1200x1200 Prime95B from Photometrics (pixel size:11 µm) and a sCMOS 2048x2048 Orca Flash 4 v2 from Hamamatsu (pixel size:6.5 µm).
DIC video-microscopy / 'Nomarski'
Embryos were examined with a Reichert Polyvar 2 microscope with DIC optics and equipped with a Hitachi HV-C20 tri-CCD camera. All contrast-dampening functions were set off, so that with the ×100 (oil immersion) objective, the final magnification on a 26-cm video screen was ×4000 with excellent contrast, such that mitochondria and intracellular vesicle trafficking could be observed. Video-sequences were recorded from the Y/C output of the camera by a Sony DHR1000 tape recorder in Digital Video (DV) format. Single video images were captured and stored on a PC from the DV videotapes, through the Sony DVK2000 capture board.
Electron microscopy
For conventional EM, Zebrafish embryos 3dpf were fixed in 2.5% glutaraldehyde in 0.1 M cacodylate buffer for 24 h, post-fixed with 1% osmium tetroxide, dehydrated in ethanol and embedded in epon as described (Raposo et al., 2001) . Epon embedding was performed as described (Hurbain et al., 2008) . Ultrathin sections of zebrafish were prepared with a Reichert UltracutS ultramicrotome (Leica Microsystems) and contrasted with uranyl acetate and lead citrate.
For ultrathin cryosectioning and immunogold labeling, zebrafish were fixed in 2% PFA, 0.2% glutaraldehyde in 0.1M phosphate buffer pH 7.4. Zebrafishes were processed for ultracryomicrotomy and immunogold labeled using PAG 10 as described (Raposo et al., 2001) .
Exosome pellets were deposited on carbonated grids and fixed in 2% PFA in 0.1 M phosphate buffer, pH 7.4. The grids were then processed for single immunogold labeled using PAG10 (Raposo et al 2011) and embedded in methyl-cellulose Uranyl Acetate 0,4%.
All samples were examined with a FEI Tecnai Spirit electron microscope (FEI Company), and digital acquisitions were made with a numeric camera (Quemesa; Soft Imaging System).
Image analysis
All imaging data was analysed using ImageJ. Mander's overlap coefficient was determined using the JACoP plugin.
Generation of EV-heatmap in zebrafish embryo
The heatmap was generated using Fiji and MATLAB software. After image acquisition, the particles (immobilized EVs at the endothelial walls) were identified after analyses of the zstacks with Fiji for each fish. The positions of these events were registered on a gray-level support image of a 3dpf zebra fish plexus by drawing dots at the position of the events. Next, all support images were put together in a z-stack, one layer corresponding to each fish. The next step was to read this support-image z-stack layer by layer with MATLAB, where the dots representing the particles were automatically detected with the function HoughCircles (Yuan-Liang Tang, Department of Information Management, Chaoyang University of Technology, Taichung, Taiwan) using the Circular Hough Transform based algorithm, giving the coordinates of the detected dots as output. Gaussian spots were then created at these coordinates, with an amplitude of each spot equal to 1. A sum projection of the different layers was generated, after which a black and white mask created with the gray level support image was applied to this sum projection. The gaussian spot amplitudes of each layers were summed to produce the heatmap. The areas of the sum projection where the gaussian spot amplitudes are higher corresponds to high density areas of events. To produce the final heatmap, a custom colormap, inspired by the jet colormap, was applied to the sum projection.
The colormap goes from black (no event) to red (high density areas).
Exosome preparation from in vitro cultured cells
Exosomes were prepared from the supernatant of 24h cultured AB.9 cells as described before (Théry et al., 2006) . Briefly, exosomes were purified from the cultured media with exosomefree serum. Differential centrifugations at 500 x g (2 x 10 min) and 2,000 x g (2 x 15min) were carried out in a standard lab culture centrifuge using 50mL tubes. Subsequent steps were carried out in an ultracentrifuge, using polyallomer tubes listed above. The 10,000 x g (2 x 30min) steps eliminated cellular debris and centrifugation at 100,000 x g (60 min) pelleted exosomes. The exosome pellet was washed once in a PBS, centrifuged at 100,000 x g for 1 h and re-suspended in 50-200 μL PBS, depending on the starting volume. Differential centrifugations at 500 g (2 x 10 min), 2,000 g (2 x 15min), 10,000g (2 x 30min) eliminated cellular debris and centrifugation at 100,000 g (60 min) pelleted exosomes. The exosome pellet was washed once in a PBS, centrifuged at 100,000 g for 1 h and re-suspended in 50-200 μL PBS, depending on the starting volume.
Exosome isolation from zebrafish embryos
NTA measurements
For NTA measurements of EV-size and concentration, concentrated samples were pre-diluted 2000x, and analyzed using a Nanosight (LM10). Samples were measured at 5 different positions in the chamber for 1 min each, with stage temperature control set at 27°C. The videos were then processed by the Nanosight software (NTA 3.2 Dev Build 3.2.16).
Label-free Mass-spectrometry
Exosomes were purified by differential ultracentrifugation as described above, and followed (for YSL derived exosomes) by an IP for GFP using GFP-trap magnetic agarose beads (Chromotek). Pull-downs were performed in biological replicates (n = 3) under agitation overnight at 4°C.
To characterize the exosome proteins, we qualitatively and quantitatively analyzed them by Orbitrap Fusion Tribrid mass spectrometry, by using a label free approach. For exosome quantification, SDS/PAGE was used without separation as a clean-up step, and only one gel slice was excised otherwise proteins were separated on SDS/PAGE and four gel slices were excised. Subsequently, gel slices were washed and proteins were reduced with 10 mM DTT before alkylation with 55 mM iodoacetamide. After washing and shrinking the gel pieces with 100% MeCN, we performed in-gel digestion using trypsin/LysC (Promega) overnight in 25 mM NH4HCO3 at 30 °C. Peptide were then extracted using 60/35/5 MeCN/H2O/HCOOH and vacuum concentrated to dryness Samples were chromatographically separated using an RSLCnano system (Ultimate 3000, Thermo Scientific) coupled to an Orbitrap Fusion Tribrid mass spectrometer (Thermo Scientific).
Peptides were loaded onto a C18 column (75-μm inner diameter × 2 cm; nanoViper Acclaim PepMapTM 100 or 300 µm x 5 mm PepMapTM 100, 5 µm, Thermo Scientific), separated and MS data acquired using Xcalibur software. Peptides separation was performed over a linear gradient of 100 min from 5% to 25% or 5% to 35% MeCN (75-μm inner diameter × 50 cm; nanoViper C18, 2 μm or 5 µm, 100Å, Acclaim PepMapTM RSLC, Thermo Scientific).
Full-scan MS was acquired in the Orbitrap analyzer with a resolution set to 120,000 and ions from each full scan were HCD fragmented and analyzed in the linear ion trap.
For identification the data were searched against the UniProtKB Zebrafish database using Sequest through proteome discoverer. Enzyme specificity was set to trypsin and a maximum of two missed cleavage site were allowed. Oxidized methionine, N-terminal acetylation, and carbamidomethyl cysteine were set as variable modifications. Maximum allowed mass deviation was set to 10 ppm for monoisotopic precursor ions and 0.6 Da for MS/MS peaks.
The resulting files were further processed using myProMS (Poullet et al., 2007) . FDR calculation used Percolator and was set to 1%. The label free quantification was performed by peptide Extracted Ion Chromatograms (XICs) computed with MassChroQ version 1.2.1 (Valot et al., 2011) . Global MAD normalization was applied on the total signal to correct the XICs for each biological replicate. Protein ratios were computed as the geometrical mean of related peptides. To estimate ratio significance, a two-tailed t test was performed and p-values were adjusted with a Benjamini-Hochberg FDR procedure with a control threshold set to 0.05. Fold change-based GO enrichment analysis was performed as in Kowal et al. (Kowal et al., 2016) .
Analysis of growth in the CVP
For height measurements, the longest distance through the z-stack was used, obtained by maximum projection in z and using a fixed point (second ISV from the right). For measurements of the (relative) surface area increase, likewise a maximum projection in z was used and compared over time. To measure proliferation, the number of nuclei were counted at different time points. As a slight mosaicism of the kdrl:nls-mKate2 line could not be fully excluded, we expressed proliferation relative to the control.
QUANTIFICATION AND STATISTICAL ANALYSIS
We performed statistical analysis (Student's two-tailed t-test for significance) using GraphPad Prism version 6.0 (GraphPad software). Unpaired analysis was used unless specified otherwise. Data distribution was assumed to be normal but this was not formally tested.
Sample sizes, statistical test and P values are indicated in the figures or figure legends.
DATA AND SOFTWARE AVAILABILITY
The mass spectrometry proteomics data have been deposited to the ProteomeXchange Consortium (Vizcaíno et al., 2014) 
